Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
Erivelton de Azevedo LopesGustavo Guimarães Moreira BalbiMaria G TektonidouVittorio PengoSavino SciasciaAmaia UgarteH Michael BelmontMaria GerosaPaul R FortinChary Lopez-PedreraLanlan JiHannah CohenGuilherme Ramires de JesúsD Ware BranchCecilia NalliMichelle PetriEsther RodriguezNina KelloRoberto Ríos-GarcésJason S KnightTatsuya AtsumiRohan WillisMaria Laura BertolacciniDoruk ErkanDanieli Castro de Oliveira Andradenull nullPublished in: Advances in rheumatology (London, England) (2021)
Our study suggests a specific profile of PAPS in Brazil with higher frequency of selected non-criteria manifestations and lupus anticoagulant positivity. Lupus anticoagulant (not triple positivity) was the major aPL predictor of a classification criteria event.